يحاول ذهب - حر
Demi Moore refuses to fade away quietly
January 18, 2025
|Mint New Delhi
Coralie Fargeat's 'The Substance' puts Moore through the wringer and gives her the spotlight
age then makes his big offer: a million bucks for a night with Diana—no aftermath, no strings. 'It's just my body,' Diana explains. 'It's not my mind.' I was glad to have that cleared up, though it does raise an interesting question: How much would you pay for an evening with Demi Moore's mind?
This is Anthony Lane's 1993 review of Indecent Proposal in The New Yorker. It's mean in a way that stings, switching from character to actor at the moment of punchline. I don't mean to single out Lane, one of the great comic stylists of film criticism. Most working critics have said worse, and less musically. We don't often imagine actors, especially big stars, reading reviews and feeling hurt. But it must happen more than we think.
Something last week made me rethink Lane's jab. Demi Moore won the Golden Globe for Best Actress, for her role as the ageing actress in The Substance, a wild body horror film by French filmmaker Coralie Fargeat. In her acceptance speech, Moore recalled how, 30 years earlier, a producer calling her a "popcorn actress" coloured her idea of herself. "I made that mean that this (award) wasn't something that I was allowed to have. That I could do movies that were successful, that made a lot of money, but that I couldn't be acknowledged, and I bought in and I believed that. And that corroded me over time, to the point where I thought, a few years ago, that maybe this was it."
هذه القصة من طبعة January 18, 2025 من Mint New Delhi.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint New Delhi

Mint New Delhi
How CCI plans to watch AI use by companies
The Competition Commission of India (CCI) on Monday proposed a self-audit for companies to keep track of how they use artificial intelligence (AI) and the data they train AI models on. Implementing such a practice comes with multiple caveats. Mint explains.
2 mins
October 08, 2025

Mint New Delhi
NAVIGATING A JOB LOSS IS NOT AS HARD AS IT SEEMS, BUT YOU SHOULD START EARLY
The best time to mend the roof is when the sun is shining, not after the rains commence. There is so much wisdom in this one sentence that it needs careful reflection. People expect life to be a smooth, sedate, upward ride, but it is anything but that. In fact, every facet of life has its ups and downs - sometimes, they are positive and at other times, they may be challenging.
3 mins
October 08, 2025
Mint New Delhi
US TARIFF-LED RISKS PERSIST FOR INDIA
The Indian economy stumbled in August, hit by the US's additional 25% tariffs on top of the 25% reciprocal levy, as external risks weighed on domestic momentum through a weakening rupee, continued selling by foreign investors, sliding stock market and slowing exports.
3 mins
October 08, 2025
Mint New Delhi
Nykaa fashion arm sashays again—spotlight on the stride
The fashion business of FSN E-Commerce Ventures Ltd (Nykaa) is showing signs of revival after several quarters of modest performance.
1 mins
October 08, 2025

Mint New Delhi
‘RBI focusing on new use cases for e-rupee’
The Reserve Bank of India (RBI) is in no rush to open up the pilots for the central bank digital currency (CBDC) to the masses and is, instead, focusing on adding more use cases to the e-rupee with a focus on cross-border transactions, T. Rabi Sankar, deputy governor of the central bank, said on Tuesday.
1 mins
October 08, 2025
Mint New Delhi
Nobel physics prize goes to pioneers of quantum mechanics
US-based scientists John Clarke, Michel Devoret and John Martinis won the 2025 Nobel Prize in Physics for “experiments that revealed quantum physics in action”, paving the way for the development of the next generation of digital technologies.
1 min
October 08, 2025
Mint New Delhi
Nvidia to continue sponsoring H-1B visas
Chipmaker Nvidia's CEO Jensen Huang said that the company will continue to sponsor H-IB visas and cover all associated costs following U.S. President Donald Trump's executive order last month that imposed a $100,000 fee on each new application, Business Insider reported on Tuesday.
1 min
October 08, 2025
Mint New Delhi
AstraZeneca to sell cancer drug in India
AstraZeneca Pharma on Tuesday said it has received approval from the national drug regulator to market a cancer treatment drug in the country.
1 min
October 08, 2025
Mint New Delhi
Fintech lending growth slows after clampdown
But delinquency and deep-stage stress are still elevated, shows report
2 mins
October 08, 2025
Mint New Delhi
CENTRAL BANK OF INDIA RATED INDIA INVOLVED BY SKOCH FOR TRANSFORMING RECRUITMENT ONBOARDING DIGITALLY
The Central Bank of India has undertaken a landmark initiative to reimagine its recruitment and onboarding practices through a comprehensive digital solution.
1 mins
October 08, 2025
Listen
Translate
Change font size